ORMP
Oramed Pharmaceuticals Inc.stockNASDAQ
At CloseNov 18, 2026 3:59:50 PM EST
3.89USD+0.517%(+0.02)164,339
After-hoursNov 18, 2026 4:00:30 PM EST
3.89USD0.000%(-0.00)
Loading…
Loading…
169.60M
Healthcare
Biotechnology
CEO
Nadav Kidron
HQ
New York, NY, USA
Previous Close
$3.87
Beta
1.19
52-Week High
$5.47 2026-08-27
52-Week Low
$2.38 2025-11-20
SMA 50
$4.30
SMA 200
$4.06
Avg. Vol 10D
157,222
Avg. Vol 30D
135,082
Avg. Vol 90D
172,152
Relative Vol
1.22
43.49M
32.75M
75.32%
1,343,457
4.29%
11.34
61%/39%
41.87%
34.08%
0.6300%
650,000
3,703
2,260
4,845
Jan 16, 2026 · $0.250
Jan 23, 2013 · 1-for-12.0005 (reverse)
144.9M
-3.2M
Oct 2, 2026
Oramed Pharmaceuticals CFO Avraham Gabay sells $90,200 in stock ·
Investing.com
ORMP Profile
oramed pharmaceuticals (nasdaqcm:ormp) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 trials under the usfda, the company is seeking to revolutionize the treatment of diabetes. read more: http://www.oramed.com/investors/corporate-presentation watch: https://www.youtube.com/watch?v=5qchxtdv9eg
ORMP Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 4.03 | 2026-11-12 | -3.23% | -5.391 |
| 1M | 4.06 | 2026-10-19 | -3.94% | 1.133 |
| 3M | 4.79 | 2026-08-19 | -18.58% | 0.926 |
| 6M | 4.33 | 2026-05-19 | -9.93% | 0.801 |
| 1Y | 2.50 | 2025-11-19 | +56.31% | 1.189 |
| 2Y | 2.30 | 2024-11-19 | +69.56% | — |
| 5Y | 26.50 | 2021-11-19 | -85.28% | 1.143 |
ORMP Stock Summary
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) stock price today is $3.90, and today's volume is 164,339. ORMP is up 0.775% today. The 30 day average volume is 135,082. ORMP market cap is $169.60M with 43.49M shares outstanding.
